Jubilant Pharmova Q2 Results: Net Profit falls 78.73% QoQ to ₹102.5 crore, Revenue grows marginally to ₹1,742.2 crore

Jubilant Pharmova Limited’s Board of Directors approved the unaudited financial results for the quarter and half-year ended September 30, 2024.

Jubilant Pharmova’s Q2 results:

• Revenue from operations: ₹1,742.2 crore
  • Quarter-on-Quarter (QoQ) increase: 1.27%
  • Year-on-Year (YoY) increase: 4.53%
• Net Profit: ₹102.5 crore
  • QoQ decrease: -78.73%
  • YoY increase: 65.06%

This reflects a slight growth in revenue but a significant decline in net profit QoQ, while showing a strong YoY improvement in profitability.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.